Platelet toll-like receptors are crucial sensors of infectious danger moieties

References

• Golebiewska EM, Poole AW. Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 2015; 29: 153–162,
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noe B. Demers M and Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost 2011; 9(Suppl 1): 56–65.
   PubMed Web of Science ®Google Scholar
• Blanchet X, Cesarek K, Brandt J, Herwald H, Teupser D, Kuchenhoff H, Karshovska E, Mause SF, Siess W, Wasmuth H, et al. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome. Thromb Haemost 2014; 112: 1277–1287.
   PubMed Web of Science ®Google Scholar
• Nording HM. Seizer P and Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6: 98,
   PubMed Web of Science ®Google Scholar
• Damien P, Cognasse F, Lucht F, Suy F, Pozzetto B, Garraud O, Hamzeh-Cognasse H. Highly active antiretroviral therapy alters inflammation linked to platelet cytokines in HIV-1-infected patients. J Infect Dis 2013; 208: 868–870,
   PubMed Web of Science ®Google Scholar
• De Stoppelaar SF. van ‘t Veer C and van der Poll T. The role of platelets in sepsis. Thromb Haemost 2014; 112: 666–677,
   PubMed Web of Science ®Google Scholar
• Nishimura S, Nagasaki M, Kunishima S, Sawaguchi A, Sakata A, Sakaguchi H, Ohmori T, Manabe I, Italiano JE Jr., Ryu T, et al. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 2015; 209: 453–466.
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R, Dilks JR, Rozenvayn N, Monahan-Earley RA. Feng D and Dvorak AM. The actin cytoskeleton differentially regulates platelet alpha-granule and dense-granule secretion. Blood 2005; 105: 3879–3887,
   PubMed Web of Science ®Google Scholar
• Thon JN, Italiano JE. Platelets: production, morphology and ultrastructure. In: P Gresele, GVR Born, C Patrono, CP Page, editors. Handbook of experimental pharmacology (pp. 3–22). Berlin, New York: Springer; 2012.
   Google Scholar
• Kapur R, Zufferey A. Boilard E and Semple JW. Nouvelle cuisine: platelets served with inflammation. J Immunol 2015; 194: 5579–5587,
   PubMed Web of Science ®Google Scholar
• George JN. Platelets. Lancet 2000; 355: 1531–1539,
   PubMed Web of Science ®Google Scholar
• Sadoul K. New explanations for old observations: marginal band coiling during platelet activation. J Thromb Haemost 2015; 13: 333–346,
   PubMed Web of Science ®Google Scholar
• Sorrentino S, Studt JD. Medalia O and Tanuj Sapra K. Roll, adhere, spread and contract: structural mechanics of platelet function. Eur J Cell Biol 2015; 94: 129–138,
   PubMed Web of Science ®Google Scholar
• Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, Speicher KD, Blair IA, Speicher DW, Grosser T, et al. Deciphering the human platelet sheddome. Blood 2011; 117: e15–26.
   PubMed Web of Science ®Google Scholar
• Van Nispen Tot Pannerden H, De Haas F, Geerts W, Posthuma G, Van Dijk S, Hf H. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 2010; 116: 1147–1156.
   PubMed Web of Science ®Google Scholar
• Panigrahi S, Ma Y, Hong L, Gao D, West XZ, Salomon RG. Byzova TV and Podrez EA. Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ Res 2013; 112: 103–112.
   PubMed Web of Science ®Google Scholar
• Thon JN, Peters CG, Machlus KR, Aslam R, Rowley J, Macleod H, Devine MT, Fuchs TA, Weyrich AS, Semple JW, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol 2012; 198: 561–574.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Garraud O, Pozzetto B, Laradi S, Hamzeh-Cognasse H. How can non-nucleated platelets be so smart?. J Thromb Haemost 2016; 14(4): 794–796.
   PubMed Web of Science ®Google Scholar
• White JG, Rao GH. Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol 1983; 112: 207–217,
   PubMed Web of Science ®Google Scholar
• Marcu MG, Zhang L. Nau-Staudt K and Trifaro JM. Recombinant scinderin, an F-actin severing protein, increases calcium-induced release of serotonin from permeabilized platelets, an effect blocked by two scinderin-derived actin-binding peptides and phosphatidylinositol 4,5-bisphosphate. Blood 1996; 87: 20–24.
   PubMed Web of Science ®Google Scholar
• Kamykowski J, Carlton P. Sehgal S and Storrie B. Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet alpha-granules. Blood 2011; 118: 1370–1373.
   PubMed Web of Science ®Google Scholar
• Battinelli EM, Markens BA, Italiano JE Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011; 118: 1359–1369,
   PubMed Web of Science ®Google Scholar
• Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B. Cognasse F and Garraud O. Platelets and infections – complex interactions with bacteria. Front Immunol 2015; 6: 82.
   PubMed Web of Science ®Google Scholar
• Watson CN, Kerrigan SW, Cox D, Henderson IR. Watson SP and Arman M. Human platelet activation by Escherichia coli: roles for FcgammaRIIA and integrin alphaIIbbeta3. Platelets 2016; 27: 535–540,
   PubMed Web of Science ®Google Scholar
• Chabert A, Hamzeh-Cognasse H, Pozzetto B, Cognasse F, Schattner M. Gomez RM and Garraud O. Human platelets and their capacity of binding viruses: meaning and challenges?. BMC Immunol 2015; 16: 26.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Hamzeh H, Chavarin P, Acquart S. Genin C and Garraud O. Evidence of toll-like receptor molecules on human platelets. Immunol Cell Biol 2005; 83: 196–198.
   PubMed Web of Science ®Google Scholar
• D’Atri LP, Etulain J, Rivadeneyra L, Lapponi MJ, Centurion M, Cheng K. Yin H and Schattner M. Expression and functionality of toll-like receptor 3 in the megakaryocytic lineage. J Thromb Haemost 2015; 13: 839–850.
   PubMed Web of Science ®Google Scholar
• Koupenova M, Vitseva O, MacKay CR, Beaulieu LM, Benjamin EJ, Mick E, Kurt-Jones EA. Ravid K and Freedman JE. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood 2014; 124: 791–802
   PubMed Web of Science ®Google Scholar
• Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008; 28: s17–24.
   PubMed Web of Science ®Google Scholar
• Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Zeni F, Pozzetto B, McNicol A. Garraud O and Cognasse F. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol 2012; 145: 189–200.
   PubMed Web of Science ®Google Scholar
• D’ Atri L, Schattner M. Platelet toll-like receptors in thromboinflammation. Front Biosci (Landmark Ed) 2017; 22: 1867–1883.
   PubMed Web of Science ®Google Scholar
• Lannan KL, Sahler J, Kim N, Spinelli SL, Maggirwar SB, Garraud O, Cognasse F. Blumberg N and Phipps RP. Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles. Front Immunol 2015; 6: 48.
   PubMedGoogle Scholar
• Koupenova M, Mick E, Mikhalev E, Benjamin EJ. Tanriverdi K and Freedman JE. Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2015; 35: 1030–1037.
   PubMed Web of Science ®Google Scholar
• Biswas S, Zimman A, Gao D. Byzova TV and Podrez EA. TLR2 plays a key role in platelet hyperreactivity and accelerated thrombosis associated with hyperlipidemia. Circ Res 2017; 121: 951–962.
   PubMed Web of Science ®Google Scholar
• Carestia A, Rivadeneyra L, Romaniuk MA, Fondevila C. Negrotto S and Schattner M. Functional responses and molecular mechanisms involved in histone-mediated platelet activation. Thromb Haemost 2013; 110: 1035–1045.
   PubMed Web of Science ®Google Scholar
• Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK. Buttle DJ and Sabroe I. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 2005; 94: 831–838.
   PubMed Web of Science ®Google Scholar
• Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S, Hayashi C, Genco CA. Iafrati M and Freedman JE. Stimulation of toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009; 104: 346–354.
   PubMed Web of Science ®Google Scholar
• Damien P, Cognasse F, Payrastre B, Spinelli SL, Blumberg N, Arthaud CA, Eyraud MA, Phipps RP, McNicol A, Pozzetto B, et al. NF-kappaB Links TLR2 and PAR1 to Soluble immunomodulator factor secretion in human platelets. Front Immunol 2017; 8: 85.
   PubMed Web of Science ®Google Scholar
• De Stoppelaar SF, Claushuis TA, Schaap MC, Hou B, Van Der Poll T, Nieuwland R, Van ‘T Veer C. Toll-Like receptor signalling is not involved in platelet response to Streptococcus pneumoniae in vitro or in vivo. PLoS ONE 2016; 11: e0156977.
   PubMed Web of Science ®Google Scholar
• Keane C, Tilley D, Cunningham A, Smolenski A, Kadioglu A, Cox D. Jenkinson HF and Kerrigan SW. Invasive Streptococcus pneumoniae trigger platelet activation via toll-like receptor 2. J Thromb Haemost 2010; 8: 2757–2765.
   PubMed Web of Science ®Google Scholar
• Assinger A, Laky M, Badrnya S. Esfandeyari A and Volf I. Periodontopathogens induce expression of CD40L on human platelets via TLR2 and TLR4. Thromb Res 2012; 130: e73–78.
   PubMed Web of Science ®Google Scholar
• Assinger A, Laky M, Schabbauer G, Hirschl AM, Buchberger E. Binder BR and Volf I. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J Thromb Haemost 2011; 9: 799–809.
   PubMed Web of Science ®Google Scholar
• Damas JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Froland SS, Rolain JM, Myrvang B. Raoult D and Aukrust P. Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. J Immunol 2006; 177: 2699–2706.
   PubMed Web of Science ®Google Scholar
• Assinger A, Kral JB, Yaiw KC, Schrottmaier WC, Kurzejamska E, Wang Y, Mohammad AA, Religa P, Rahbar A, Schabbauer G, et al. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol 2014; 34: 801–809.
   PubMed Web of Science ®Google Scholar
• Andonegui G, Kerfoot SM, McNagny K, Ebbert KV. Patel KD and Kubes P. Platelets express functional toll-like receptor-4. Blood 2005; 106: 2417–2423.
   PubMed Web of Science ®Google Scholar
• Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH. Freedman J and Semple JW. Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006; 107: 637–641.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Lafarge S, Chavarin P. Acquart S and Garraud O. Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9. Intensive Care Med 2007; 33: 382–384.
   PubMed Web of Science ®Google Scholar
• Damien P, Cognasse F, Eyraud MA, Arthaud CA, Pozzetto B, Garraud O, Hamzeh-Cognasse H. LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand. BMC Immunol 2015; 16: 3.
   PubMed Web of Science ®Google Scholar
• Vancraeyneste H, Charlet R, Guerardel Y, Choteau L, Bauters A, Tardivel M, Francois N, Dubuquoy L, Soloviev D, Poulain D, et al. Short fungal fractions of beta-1,3 glucans affect platelet activation. Am J Physiol Heart Circ Physiol 2016; 311: H725–734.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang H, Zhang M, Liu J. Lv B and Chen F. HMGB1: a novel protein that induced platelets active and aggregation via toll-like receptor-4, NF-kappaB and cGMP dependent mechanisms. Diagn Pathol 2015; 10: 134.
   PubMed Web of Science ®Google Scholar
• Rigg RA, Healy LD, Nowak MS, Mallet J, Thierheimer ML, Pang J. McCarty OJ and Aslan JE. Heat shock protein 70 regulates platelet integrin activation, granule secretion and aggregation. Am J Physiol Cell Physiol 2016; 310: C568–575.
   PubMed Web of Science ®Google Scholar
• Nocella C, Carnevale R, Bartimoccia S, Novo M, Cangemi R, Pastori D, Calvieri C. Pignatelli P and Violi F. Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production. Thromb Haemost 2017; 117: 1558–1570.
   PubMed Web of Science ®Google Scholar
• Matus V, Valenzuela JG, Hidalgo P, Pozo LM, Panes O, Wozniak A, Mezzano D, Pereira J, Saez CG. Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving toll like receptor 4. PLoS ONE 2017; 12: e0185431.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Pozzetto B. McNicol A and Garraud O. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 2008; 141: 84–91.
   PubMed Web of Science ®Google Scholar
• Brown GT, Narayanan P, Li W. Silverstein RL and McIntyre TM. Lipopolysaccharide stimulates platelets through an IL-1beta autocrine loop. J Immunol 2013; 191: 5196–5203.
   PubMed Web of Science ®Google Scholar
• Schrottmaier WC, Kral JB, Zeitlinger M, Salzmann M. Jilma B and Assinger A. Platelet activation at the onset of human endotoxemia is undetectable in vivo. Platelets 2016; 27: 479–483.
   PubMed Web of Science ®Google Scholar
• Kaufman T, Magosevich D, Moreno MC, Guzman MA, D’Atri LP, Carestia A, Fandino ME. Fondevila C and Schattner M. Nucleosomes and neutrophil extracellular traps in septic and burn patients. Clin Immunol 2017; 183: 254–262.
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463–469.
   PubMed Web of Science ®Google Scholar
• Noubouossie DF, Whelihan MF, Yu YB, Sparkenbaugh E, Pawlinski R, Dm M, Ns K. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood 2017; 129: 1021–1029.
   PubMed Web of Science ®Google Scholar
• McDonald B, Davis RP, Kim SJ, Tse M, Esmon CT. Kolaczkowska E and Jenne CN. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood 2017; 129: 1357–1367.
   PubMed Web of Science ®Google Scholar
• Gaertner F, Ahmad Z, Rosenberger G, Fan S, Nicolai L, Busch B, Yavuz G, Luckner M, Ishikawa-Ankerhold H, Hennel R, et al. Migrating Platelets are mechano-scavengers that collect and bundle bacteria. Cell 2017; 171: 1368–1382 e1323.
   PubMed Web of Science ®Google Scholar
• Stark RJ. Aghakasiri N and Rumbaut RE. Platelet-derived toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia. PLoS ONE 2012; 7: e41254.
   PubMed Web of Science ®Google Scholar
• Gurses KM, Kocyigit D, Yalcin MU, Canpinar H, Oto MA, Ozer N, Tokgozoglu L, Guc D and Aytemir K. Enhanced platelet toll-like receptor 2 and 4 expression in acute coronary syndrome and stable angina pectoris. Am J Cardiol 2015; 116: 1666–1671.
   PubMed Web of Science ®Google Scholar
• Schmid W, Novacek G, Vogelsang H, Papay P, Primas C. Eser A and Panzer S. Platelets Toll-like receptor-4 in Crohns disease. Eur J Clin Invest 2017; 47: 109–116.
   PubMed Web of Science ®Google Scholar
• Henke PK, Mitsuya M, Luke CE, Elfline MA, Baldwin JF, Deatrick KB, Diaz JA, Sood V, Upchurch GR, Wakefield TW, et al. Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol 2011; 31: 43–49.
   PubMed Web of Science ®Google Scholar
• El-Sayed OM, Dewyer NA, Luke CE, Elfline M, Laser A, Hogaboam C, Kunkel SL and Henke PK. Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice. J Vasc Surg 2016; 64: 1450–1458 e1451.
   PubMed Web of Science ®Google Scholar
• Hally KE, La Flamme AC, Larsen PD and Harding SA. Toll-like receptor 9 expression and activation in acute coronary syndrome patients on dual anti-platelet therapy. Thromb Res 2016; 148: 89–95.
   PubMed Web of Science ®Google Scholar
• Anabel AS, Eduardo PC, Pedro Antonio HC, Carlos SM, Juana NM, Honorio TA, Nicolas VS and Sergio Roberto AR. Human platelets express toll-like receptor 3 and respond to poly I:C. Hum Immunol 2014; 75: 1244–1251.
   PubMed Web of Science ®Google Scholar
• Blum P, Pircher J, Merkle M, Czermak T, Ribeiro A, Mannell H, Krotz F, Hennrich A, Spannagl M, Koppel S, et al. Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C. Cell Mol Immunol 2017; 14(12): 986–996.
   PubMed Web of Science ®Google Scholar
• Akinosoglou K, Alexopoulos D. Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 2014; 133: 131–138.
   PubMed Web of Science ®Google Scholar
• Dewitte A, Lepreux S, Villeneuve J, Rigothier C, Combe C, Ouattara A and Ripoche J. Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critical ill patients? Ann Intensive Care 2017; 7: 115.
   PubMed Web of Science ®Google Scholar
• Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, et al. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 2015; 35: 2562–2570.
   PubMed Web of Science ®Google Scholar
• Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. Jama 2013; 309: 1154–1162.
   PubMed Web of Science ®Google Scholar
• Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 2010; 38: 1685–1694.
   PubMed Web of Science ®Google Scholar
• Monnet E, Lapeyre G, Poelgeest EV, Jacqmin P, Graaf K, Reijers J, Moerland M, Burggraaf J and Min C. Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS. Clin Pharmacol Ther 2017; 101: 200–208.
   PubMed Web of Science ®Google Scholar
• El-Tanbouly GS, El-Awady MS, Megahed NA, Salem HA, El-Kashef HA. The NF-kappaB inhibitor celastrol attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats. Environ Toxicol Pharmacol 2017; 50: 175–182.
   PubMed Web of Science ®Google Scholar
• Park SH, Baek SI, Yun J, Lee S, Yoon DY, Jung JK, Jung SH, Hwang BY, Hong JT, Han SB, et al. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid. J Immunol 2015; 194: 1122–1130.
   PubMed Web of Science ®Google Scholar
• Huber-Lang M, Barratt-Due A, Pischke SE, Sandanger O, Nilsson PH, Nunn MA, Denk S, Gaus W, Espevik T and Mollnes TE. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice. J Immunol 2014; 192: 5324–5331.
   PubMed Web of Science ®Google Scholar
• Spiller S, Elson G, Ferstl R, Dreher S, Mueller T, Freudenberg M, Daubeuf B, Wagner H and Kirschning CJ. TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice. J Exp Med 2008; 205: 1747–1754.
   PubMed Web of Science ®Google Scholar